Resultados de la búsqueda 101-110 of 3849 for treatment resistant depression
... resistant to platinum drugs. Effect of Agent ... drug alone in treating ... Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and ...
... treatment recommendations. This application's objective is to obtain the data necessary to plan an adequately powered randomized clinical trial (RCT) across ...
... refractory (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
... Treat Subjects with Relapsed or Refractory ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... resistant chronic lymphocytic leukemia.
The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...
The purpose of this study is to compare, in a non-inferiority fashion, the progression-free survival (PFS) in patients with metastatic refractory gastric/ ...
KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Jacksonville, Fla., Rochester, Minn., ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?